Brightgene Bio-Medical Technology Co., Ltd. — Investor Relations & Filings
About Brightgene Bio-Medical Technology Co., Ltd.
Brightgene Bio-Medical Technology Co., Ltd. is a research-driven pharmaceutical enterprise specializing in the development and manufacturing of high-end generic drugs and innovative medicines. The company focuses on complex active pharmaceutical ingredients (APIs) and finished dosage forms across therapeutic areas such as oncology, anti-infectives, cardiovascular diseases, and metabolic disorders. Brightgene leverages advanced technology platforms, including microbial fermentation, high-end chemical synthesis, and specialized drug delivery systems, to produce high-barrier pharmaceutical products. Its portfolio includes a range of antifungal, antiviral, and immunosuppressant agents. The company maintains a global supply chain, providing high-quality pharmaceutical solutions to international markets while adhering to rigorous quality standards and regulatory requirements.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 国联民生证券承销保荐有限公司关于博瑞生物医药（苏州）股份有限公司为控股子公司提供财务资助的核查意见 | 2026-03-19 | Chinese | |
| 2025年度独立董事述职报告-吴英华 | 2026-03-19 | Chinese | |
| 关于开展外汇套期保值业务的公告 | 2026-03-19 | Chinese | |
| 公证天业会计师事务所（特殊普通合伙）关于公司2025年度募集资金存放、管理与使用情况鉴证报告 | 2026-03-19 | Chinese | |
| 2025年年度报告 | 2026-03-19 | Chinese | |
| 2025年度审计报告 | 2026-03-19 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 39080728 | 国联民生证券承销保荐有限公司关于博瑞生物医药（苏州）股份有限公司为控股子公司提供财务资助的核查意见 | 2026-03-19 | Chinese | ||
| 39080721 | 2025年度独立董事述职报告-吴英华 | 2026-03-19 | Chinese | ||
| 39080718 | 关于开展外汇套期保值业务的公告 | 2026-03-19 | Chinese | ||
| 39080717 | 公证天业会计师事务所（特殊普通合伙）关于公司2025年度募集资金存放、管理与使用情况鉴证报告 | 2026-03-19 | Chinese | ||
| 39080715 | 2025年年度报告 | 2026-03-19 | Chinese | ||
| 39080709 | 2025年度审计报告 | 2026-03-19 | Chinese | ||
| 39080629 | 2026年度“提质增效重回报”行动方案 | 2026-03-19 | Chinese | ||
| 39080626 | 董事会审计委员会2025年度履职情况报告 | 2026-03-19 | Chinese | ||
| 39080625 | 董事会对独立董事独立性自查情况的专项报告 | 2026-03-19 | Chinese | ||
| 39080624 | 2025年度募集资金存放、管理与使用情况的专项报告 | 2026-03-19 | Chinese | ||
| 39080622 | 2025年度独立董事述职报告-陈新 | 2026-03-19 | Chinese | ||
| 39080615 | 第四届董事会独立董事第十次专门会议决议 | 2026-03-19 | Chinese | ||
| 39080614 | 2025年度内部控制审计报告 | 2026-03-19 | Chinese | ||
| 39080609 | 关于申请2026年度金融机构授信及提供担保的公告 | 2026-03-19 | Chinese | ||
| 39080608 | 国联民生证券承销保荐有限公司关于博瑞生物医药（苏州）股份有限公司开展远期外汇交易业务的核查意见 | 2026-03-19 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Brightgene Bio-Medical Technology Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58200/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58200 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58200 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58200 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58200}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Brightgene Bio-Medical Technology Co., Ltd. (id: 58200)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.